Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks

February 4, 2025
Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocksMizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks

Jared Holz, Mizuho Securities America healthcare sector strategist, joins ‘Squawk Box’ to break down the quarterly earnings results of Merck and Pfizer, 2025 outlook for pharmaceutical stocks, and more.

Share This

Latest Mizuho News

Mizuho Americas and Pursuit Launch AI Nonprofit Build Corps

Mizuho Americas and Pursuit Launch AI Nonprofit Build Corps

February 11, 2026
Novo Nordisk is being more cautious on Medicare, says Mizuho’s Holz

Novo Nordisk is being more cautious on Medicare, says Mizuho’s Holz

February 4, 2026
Paypal’s network value is still huge following leadership shuffle, says Mizuho’s Dan Dolev

Paypal’s network value is still huge following leadership shuffle, says Mizuho’s Dan Dolev

February 3, 2026

Mizuho news from around the globe

back-to-top-blue